Use of serotype specific serology (IgA & IgG) in the etiologic diagnosis of childhood pneumococcal pneumonia: First results from the pediatric pneumococcal pneumonia (3P) trial

A. Malfroot, I. De Schutter, J. Smet, P. Smeesters, F. Surmont, D. Tuerlinckx, M. Raes, J. Tresnie, A. Vergison, J. Verhaegen, F. Mascart (Brussels, Gosselies, Louvain-la-Neuve, Yvoir, Hasselt, Louvain, Belgium)

Source: Annual Congress 2010 - Childhood pneumonia: from prevention to complications
Session: Childhood pneumonia: from prevention to complications
Session type: Oral Presentation
Number: 5366
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Malfroot, I. De Schutter, J. Smet, P. Smeesters, F. Surmont, D. Tuerlinckx, M. Raes, J. Tresnie, A. Vergison, J. Verhaegen, F. Mascart (Brussels, Gosselies, Louvain-la-Neuve, Yvoir, Hasselt, Louvain, Belgium). Use of serotype specific serology (IgA & IgG) in the etiologic diagnosis of childhood pneumococcal pneumonia: First results from the pediatric pneumococcal pneumonia (3P) trial. Eur Respir J 2010; 36: Suppl. 54, 5366

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Immunoglobulin G antibodies to pneumococcal surface protein A (PspA) families in serum of adults with pneumococcal community-acquired pneumonia in China
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008

Characteristics of patients with serotype 5 pneumococcal pneumonia
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020


Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013)
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


LATE-BREAKING ABSTRACT: Pneumococcal serotypes causing community-acquired pneumonia (CAP) among hospitalized adults in Spain using a new urinary antigen detection (UAD) test. The CAPA study
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014


Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia
Source: Eur Respir J 2010; 36: 1073-1079
Year: 2010



The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012



Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003


Lower concentration of anti-capsular polysaccharide IgG antibodies (AB) in patients with pneumococcal respiratory tract infections (RTI)
Source: Eur Respir J 2003; 22: Suppl. 45, 546s
Year: 2003

Chlamydia pneumonia (CP), Mycoplasma pneumonia (MP) and virus antibody titres in acute exacerbations of asthma (BA) and chronic bronchitis (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 234s
Year: 2001

Utility of serum PCR in the diagnosis of pneumococcal pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 540s
Year: 2001

Clinical features of patients with pneumococcal urinary antigen positivity, in a cohort of hospitalised community acquired pneumonia
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012

Could procalcitonin (PCT) be a marker of effectiveness of antibiotic treatment (ABT) in pregnant with not severe community-acquired pneumonia (CAP)?
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015


Community-acquired pneumonia (CAP) with cytomegaloviral (CMV) persistence at young adults: prevalence and reciprocal burdening
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Source: Eur Respir J 2003; 21: 209-214
Year: 2003



An outbreak of streptococcus pneumonia serotype 1 pneumonia in a UK primary school
Source: Annual Congress 2007 - Paediatric respiratory epidemiology: rare diseases, infectious diseases and asthma
Year: 2007


A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021
Year: 2022



LATE-BREAKING ABSTRACT: Differences in S. pneumoniae serotypes distribution causing CAP in hospitalized adults in Spain according to comorbidities by a new urinary antigen detection (UAD) test. The CAPA study
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015


Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013




Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017